#ASCO16 and #skincancer #cancerawareness

Read the #Keytruda #pembrolizumab #ASCO16 results now on #medipaper #ImmuneCheckPoint #melanoma #nsclc #skincancerhttps://t.co/zvU3tthBPP

— MEDIPAPER | 醫學作家香港 (@MediPaper) May 20, 2016